Emerging Insights on Adverse Events During ART and Implications for Treatment

Download All
In this comprehensive online program led by expert faculty, review clinical strategies for applying the latest safety and tolerability data when selecting or modifying individualized ART regimens for patients with HIV infection.
Eric S. Daar, MD
Gregory Huhn, MD, MPHTM

Clinical Focus Modules

Review expert discussion on how new data from IAS 2021 expand our understanding of the adverse event profiles of specific ART regimens, with particular focus on weight, BMI, insulin resistance, and other metabolic parameters.

Eric S. Daar, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: September 22, 2021 Expired: No longer available for credit

Review downloadable slides on adverse events associated with current and emerging ART regimens.

Eric S. Daar, MD Released: September 22, 2021

Gain expert insight on new data from fall 2021 HIV conferences that expand our understanding of adverse events associated with ART, with particular emphasis on weight gain, metabolic complications, and pregnancy.

Gregory Huhn, MD, MPHTM Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: December 22, 2021 Expired: December 21, 2022

Review downloadable slides on safety of ART regimens, including recent data on weight gain, metabolic complications, and pregnancy.

Released: December 22, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings